Sonnet BioTherapeutics Holdings, Inc.

SONN · NASDAQ
Analyze with AI
9/30/2025
9/30/2024
9/30/2023
9/30/2022
Operating Activities
Net Income-$16-$7-$19-$30
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$1
Change in WC$0-$2-$3$0
Other Non-Cash$3$0$0$1
Operating Cash Flow-$13-$9-$21-$28
Investing Activities
PP&E Inv.$0-$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0$0
Investing Cash Flow-$0-$0-$0-$1
Financing Activities
Debt Repay.$0$0-$0$0
Stock Issued$8$4$21$2
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$26$3$0$2
Financing Cash Flow$26$6$21$4
Forex Effect$0$0$0$0
Net Chg. in Cash$13-$2-$1-$25
Supplemental Information
Beg. Cash$0$2$3$28
End Cash$13$0$2$3
Free Cash Flow-$13-$9-$22-$29